Table 1.
Receptor for advanced glycation end products main ligands and their functions.
Ligand | Ligand family | Ligand-binding region | Function | Related disease |
---|---|---|---|---|
Advanced glycation end products | AGEs | V-type | Advanced glycation endproducts are present in high levels in diabetes | Diabetes |
HMGB1 | HMGB1 | V-type | Involved in cell stress mechanisms. It also induces cellular migration | Tumor outgrowth |
S100b | S100 calgranulins | V-type | Calcium-binding protein that is related to Alzheimer's disease | Alzheimer's disease |
S100A6 | S100 calgranulins | C2-type | Calcium-binding protein that binds to a different domain | Alzheimer's disease |
Aβ | Aβ | Aβ/oligomer – V-type Aggregate – C1 type | Oligomer species appears more pathogenic. Aβ transport at the blood–brain barrier, cerebral blood flow reduction and neuroinflammation | Alzheimer's disease |
Mac-1 | β2-integrin | VC1 subunit | Involved with leukocyte recruitment relevant in inflammatory disorders | Diabetes |
Transthyretin | Transthyretin | VC1 subunit | Associated with extracellular amyloid deposits that lead to degeneration of neurons in the peripheral nerve | Alzheimer's disease |
LPS | LPS | VC1 subunit | A bioactive component of bacterial cell walls, it can bind with RAGE to regulate inflammatory responses | LPS-induced septic shock |
Phosphatidylserine | Phospholipid | Bind on soluble RAGE | Assists in the clearance of apoptotic cells | Diabetes and atherosclerosis |
Aβ: Amyloid-β; LPS: Lipopolysaccaride; RAGE: Receptor for advanced glycation end products.